Chapter 61: Common Hematological and Immunological Complaints

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement, not replace the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

You're looking at a patient's arm, right?

And there's this massive fading greenish yellow bruise.

They tell you they just bumped into a coffee table.

Yeah, happens all the time.

Right, but then you glance at their chart and their platelet count is 25 ,000.

Oh boy.

Yeah.

Suddenly that bruise isn't just clumsy, it is a spontaneous bleed and a massive clinical red flag.

So welcome to the study session.

Today we are taking chapter 61 from your primary care text and transforming it from, you know, flat pages into real world clinical survival skills.

Exactly.

Because if you are an advanced practice nursing student gearing up for a major exam or about to step onto the floor for clinicals, this deep dive is built specifically for you.

We really know you're drinking from a fire hose of information right now.

Oh yeah, it's overwhelming.

So our goal is not to just throw flashcard facts at you.

We are going to actually trace the clinical logic of four incredibly common hematological and immunological complaints.

Bruising, fatigue, fever, and lymphadenopathy.

Right, we will start down at the foundational path of physiology, work our way up to your clinical assessment, navigate the differential diagnosis, and then finally arrive at safe patient -centered management.

Because if you understand the why behind a symptom,

the diagnosis naturally follows.

It really does, it just clicks.

Okay, let's unpack this.

Starting with our very first clinical presentation, which is bruising or ecumosis.

Good place to start.

When I think about the pathophysiology of a bruise, I honestly imagine an environmental cleanup site.

Like the extravasated blood, the blood that has leaked out of the ruptured vessels is this toxic spill just sitting in the interstitial tissue.

That's a great visual.

Right, and your body's macrophages are the hazmat cleanup crew rushing to the site.

Yeah, that analogy actually works perfectly to explain the visual symptoms.

Because when those macrophages invade the area, to act as the cleanup crew,

there is a concurrent release of histamine.

Oh, so that's why it swells up.

Exactly.

That histamine release is why a fresh bruise is often associated with localized edema.

You see swelling because the body is literally flooding the area with resources.

Makes sense.

And then the macrophages get to work by physically engulfing the red blood cells to clear that extravasated blood out of the interstitial space.

And the hazmat crew doesn't just sweep the blood under the rug, right?

They actually dismantle the red blood cells right there on site.

Yes, they do.

Because that dismantling process is what gives us the classic visual timeline of a bruise.

Like, as a clinician, you can use the changing colors of the bruise to estimate how old the injury is.

You can.

Because it is a highly reliable biochemical timeline.

When the macrophages break down those engulfed red blood cells, they excrete two distinct pigments,

hemocytarin and hematoidin.

Okay, hemocytarin and hematoidin.

Right.

Hemocytarin is rich in iron, so it leaves a brown stain.

Got it.

And hematoidin leaves a yellow stain.

So let's track the colors based on that chemistry.

Initially, you have the redness from the freshly pulled erythrocytes.

The actual blood.

Right.

Then, within one to two days, as the blood deoxygenates, that redness transitions into a blue or purple hue.

And it can even darken to black over the next few days.

Then comes the shift to green, right?

Yeah, around one week after the initial onset, you see that color change to green as the hemoglobin is further degraded.

Wow, okay.

And finally, as the hemocytarin and hematoidin are fully processed and left behind, the bruise acquires that yellowish -brown appearance, which gradually fades away.

And what if it's a hematoma?

Well, if you were assessing a hematoma, which is a much larger three -dimensional collection of blood pooling under the skin,

that timeline is extended.

They require much more time for the macrophages to resolve than standard ecumosis.

That makes sense.

So that covers the normal physiological response to blunt trauma.

But as an APRN, spontaneous bruising is what really keeps me up at night.

Oh, absolutely.

It should.

So when should the listener's internal clinical alarm bells start ringing?

Well, if a patient is bruising without trauma,

your immediate thought must jump to intrinsic factors,

primarily thrombocytopenia, which is a critically low platelet count.

Because platelets form the clots.

Exactly.

Platelets are integral to forming blood clots.

If your patient's platelet count drops below 50 ,000 cells per milliliter, they're at risk for bruising from incredibly minor, almost unnoticeable trauma.

And what was the threshold for spontaneous bruising?

If that count drops below 30 ,000 cells per milliliter, you are now in the territory of severe spontaneous bruising, particularly presenting on the extremities, like the arms and the legs.

Man, 30 ,000 is so low.

What causes that kind of severe, sudden drop in platelets?

Your differential diagnosis has to expand here.

You have to consider hemocological cancers, like leukemia or myeloma.

Because they crowd out the bone marrow.

Precisely.

These diseases produce abnormal malignant cells in the blood and bone marrow that crowd out healthy production, causing normal cells, like platelets, to plummet.

What else should we be thinking about?

You also need to assess for hemolytic anemia, hypersensitivity vasculitis, and nutritional deficits, specifically an inadequate dietary intake of vitamin K, which is essential for the clotting cascade.

Okay, vitamin K.

And crucially, you must keep in mind social factors.

Unexplained or suspicious bruising might be your very first and sometimes only clue to domestic violence or self -inflicted injury.

That is such an important point.

We also have to look at our own prescribing habits, though, right, like chronic use of corticosteroids literally weakens the vascular walls, making them prone to leaking erythrocytes.

Yeah, iatrogenic causes are huge.

And anticoagulants are a massive culprit.

Honestly, managing anticoagulants in primary care makes me incredibly nervous.

The therapeutic window for something like Warfarin is just so narrow.

It really is a high -stakes medication.

Warfarin is often used for disease -related prophylaxis, like preventing the formation of valvular thrombi in a patient with atrial fibrillation.

Right, and our target INR is usually, what, 2 .0 to 3 .0?

Exactly, your target is usually to keep the patient's international normalized ratio, or INR, between 2 .0 and 3 .0.

So if I'm starting a patient on Warfarin, how do I build them up to that range safely?

Walk me through the guidelines.

OK, so you begin with an initial loading dose.

This is typically two to five milligrams per day for the first three days.

OK, two five milligrams for three days.

Right.

After those three days, you must measure their prothrombin time, or PT, and their INR.

That initial period initiates the anticoagulation process.

And then we move to maintenance.

Yeah, from there, maintenance dosages usually range from two to 7 .5 milligrams daily.

Sometimes you have to go higher than 10 milligrams, but only if the INR dictates it.

OK, let's say a worst case scenario.

A patient comes into the clinic covered in spontaneous bruises, and their lab work shows an INR of 5 .0.

They are experiencing an overdose.

Yeah.

My instinct is to just slash their daily dose and have to correct it.

Is that the right move?

Actually, no.

You do not just lower it.

Really?

Step one, you withhold the therapy entirely for one or more days.

Oh, just stop it completely.

Just stop it.

Step two, if there is active bleeding present, you consider starting reversal therapy with vitamin K.

OK, that makes sense.

Step three, you re -evaluate the PT and INR within three to five days of stopping the medication.

And finally, once the levels drop back down to a safe range, you restart the treatment at a lower dose than they were previously taking.

Wow, OK.

Hold.

Maybe vitamin K, re -evaluate in three to five days, then restart lower.

Had it.

So we just talked about how hematological cancers and their treatments can destroy platelets and cause spontaneous bruising.

Right.

But those exact same cancers and chemotherapies are also infamous for triggering our second major clinical complaint, which is fatigue.

Oh, yes, the dreaded fatigue.

It is notoriously the most frustrating, vague complaint a patient can bring into the clinic.

I mean, how do we even begin to organize our clinical reasoning around the phrase, I'm just tired?

I know, it's tough.

You start by splitting the complaint into two categories based on duration,

acute versus chronic.

OK, acute is less than what, a few weeks?

Roughly, yeah.

Acute fatigue is usually straightforward.

It is most often linked to viral or bacterial infections.

In fact, acute fatigue often serves as an early warning sign of an impending fever.

So you treat the underlying infection and the fatigue resolves.

Exactly.

Chronic fatigue, however, lasts for months, and that requires real detective work.

Since the patient rarely knows the root cause, you really have to ask the right assessment questions.

And the best diagnostic tool you have for chronic fatigue is the clock.

Yes, the timing of the fatigue offers massive insights into the underlying etiology.

So what do we ask them?

Ask the patient how their fatigue shifts throughout the day.

If they report that their fatigue worsens over the course of the day, but significantly abates after rest, that pattern strongly suggests an underlying medical or somatic condition, like chronic anemia.

Why does anemia follow that specific daily pattern, like worsening as the day goes on?

Because of oxygen demand.

With chronic anemia, the patient has a decreased oxygen carrying capacity in their blood.

Right, fewer red blood cells.

Exactly.

So as they go about their day moving around and exerting themselves, their body's oxygen demand outpaces what the blood can actually supply.

And they just hit a wall.

Yeah, the physical deficit compounds and the fatigue builds.

Rest helps, because it physically lowers the body's oxygen demand, allowing the system to catch up.

OK, but what if the patient reports the exact opposite pattern?

Like, they wake up completely exhausted, the fatigue is worse the moment they open their eyes, but it actually improves after they force themselves up and exercise.

Then you are looking at functional fatigue.

This pattern is highly associated with mental health disorders.

Ah, OK.

In primary care, depression and anxiety are cited as the most common comorbidities underlying complaints of fatigue.

A mental health disorder is far more likely to be the root cause of chronic fatigue in your clinic than some rare somatic disease.

But we still have to rule out those dangerous physical conditions first, and we have to be on high alert for red flag findings, especially regarding cancer, because cancer -related fatigue doesn't follow the rules of medical or functional fatigue, right?

No, it is entirely unique.

Cancer -related fatigue is described by patients as paralyzing.

Paralyzing, wow.

Yeah, it comes on suddenly.

It is completely unrelated to physical exertion, and crucially, it is not relieved by rest or sleep.

A nap does not fix it.

Furthermore, it can persist long after the cancer treatment itself has concluded.

Here's where it gets really interesting, though.

If we are leaning toward a somatic cause and the patient's fatigue worsens with exertion, we might suspect anemia.

What specific physical exam findings should the student look for to confirm that suspicion before the labs even come back?

You are looking for visual signs of decreased tissue perfusion.

So pale skin.

Not just skin.

Look for conjunctival power in the eyes.

Check for pale nail beds.

Exam the mouth for pale gingivet in a pale tongue.

Oh, the gums and tongue, right.

And finally, check their heart rate.

You will often find sinus tachycardia because the heart is pumping faster, desperately trying to compensate for the lower oxygen -carrying capacity of the blood.

Okay, so tachycardia and power.

We know acute fatigue is often the body's early warning system that an infection is brewing, but the main event of that infection when the immune system actively goes to war is our third clinical topic,

fever.

Right, and to understand fever, we first must define the normal baseline.

On average, normal body temperature is 98 .6 degrees Fahrenheit or 37 degrees Celsius.

And it fluctuates, right?

It does.

It is perfectly normal for that baseline to fluctuate by plus or minus 0 .9 degrees Fahrenheit or 0 .5 degrees Celsius, depending on the time of day.

So what pushes the temperature above that normal daily fluctuation?

What actually causes the fever?

Inflammatory immune mediators, specifically interleukins like IL -6 and tumor necrosis factor alpha, or TNF alpha.

Okay, IL -6 and TNF alpha.

These molecules act as pyrogens.

They travel to the hypothalamus and actively raise the body's thermal set point.

To burn it out.

Exactly.

The physiological goal is to create an internal environment that is hostile and non -conducive to microbial growth and replication.

The body is literally trying to burn the infection out.

But you know, when you are standing in the clinic and an 80 -year -old patient suddenly presents with severe confusion, your mind might instantly jump to dementia or a stroke.

But there is a massive geriatric exception to the rule of fevers.

This is a critical safety consideration.

As we age, our immune system undergoes senescence.

It weakens.

Right.

Therefore, an older adult might not be capable of mounting a robust febrile response, even to a life -threatening infection.

Their fever might be blunted, or they might not mount a fever at all.

That's terrifying.

It is.

Do not let the absence of a fever in an older adult trick you into ruling out infection.

You must look for alternative signs.

Sudden malaise, profound fatigue, decreased appetite, decreased mentation, delirium, or sudden confusion.

Okay.

That is huge pearl for clinicals.

Let's categorize fevers by magnitude and duration because the numbers really help narrow the differential.

Acute fevers are defined as temperatures greater than 101 .3 degrees Fahrenheit, or 38 .5 degrees Celsius.

Right.

And these are your typical upper respiratory infections, gastroenteritis, and UTIs.

But chronic or low -grade fevers have a right around 100 .4 degrees Fahrenheit, or 38 degrees Celsius.

Yes.

And when you see a persistent low -grade fever of 100 .4, your mind should shift to infectious hepatitis, tuberculosis, sinusitis, dental abscesses, or prostatitis.

What about monoc?

It is also highly characteristic of infectious mononucleosis, particularly peaking in the third and fourth weeks after symptoms initially start.

We discussed cancer earlier.

Is a fever a reliable early warning sign of malignancy?

Usually no.

Fever is typically an advanced sign that a solid cancer has spread or metastasized.

It is rarely an early symptom.

Are there any exceptions?

The major exception being blood cancers, like leukemia or lymphoma, where fever can present much earlier.

And what about the cancer therapies themselves?

Can they cause a fever?

Absolutely.

You must watch for neutropenic fever in patients with underlying neutropenia from their treatments.

Because they don't have the white blood cells to fight back.

Right.

In these severely immunocompromised patients, a fever is often the first, and sometimes the only, sign of a lethal infection.

You also have to be aware of cytokine release syndrome, which is triggered by therapies like CAR or T -cell therapy, or cytolytic chemotherapy.

Fever is a cardinal symptom of this massive systemic inflammatory response.

Let's talk about the dreaded fever of unknown origin, or FUO.

Because the criteria for this diagnosis depend entirely on the clinical setting.

They do.

It's very specific.

For an ambulatory outpatient clinic, an FUO is defined as a fever greater than 101 .3 degrees Fahrenheit, or 38 .5 Celsius.

That occurs on at least three occasions over a three week period.

Correct.

But for a hospitalized patient, the criteria is an unexplained fever persisting for just one week.

Why the massive difference in timelines?

It comes down to the intensity of observation.

In a hospital, we are running high level diagnostics around the clock.

If a patient has an unexplained fever for one full week in that highly monitored, tightly controlled environment, despite standard diagnostic evaluation, that is a massive clinical red flag.

But in outpatient, it's just slower.

Exactly.

In an outpatient ambulatory clinic, care moves slower.

A patient might only take their temperature intermittently.

It takes about three weeks of recurring fevers to establish that same troubling pattern of unknown origin in the outpatient setting.

Let's put this into practice with a clinical reasoning case study.

So imagine a middle -aged female patient presents to your clinic with a three day history of a fever hitting 102 .2 degrees Fahrenheit, or 39 Celsius.

Correct.

She reports a non -productive cough, chills, and inspiratory chest discomfort.

And when you percuss her lungs, they are dull at the bases, though otherwise clear.

Okay, synthesizing those findings, the cough, the inspiratory pain, and the dullness to percussion at the bases, which indicates fluid or consolidation,

the clinical reasoning points strongly to a pulmonary consolidative process, like pneumonia.

So what's our move?

The priority diagnostic plan is to order a chest X -ray and a complete blood count to evaluate that specific pulmonary infection.

Okay, do we order blood cultures for this patient just to be safe?

No, you do not order blood cultures in this specific scenario.

Why not?

First, the patient has clear focal symptoms localizing the source of the infection to the lungs.

Second, a fever of 102 .2 degrees Fahrenheit is not high enough to suggest a widespread systemic infection or bacteremia.

Ah, I see.

Blood cultures are indicated when you suspect a systemic infection, which usually presents with much higher fevers, typically in excess of 104 degrees Fahrenheit.

Good to know.

One final note on fevers before we move on.

We have to consider environmental toxins, like drugs, both illicit and prescribed, as well as agricultural chemicals like pesticides and herbicides.

They can actually induce fevers.

And those chemically induced fevers are incredibly tricky to diagnose.

Because they don't follow the normal rules.

Right, they tend to follow an insidious, indolent course.

They just drag on over time, demonstrating random peaks and troughs, and are often completely devoid of any other physical diagnostic signs.

Well, the exact same interleukins and tumor necrosis factors that turn up the body's thermostat to cause a fever, they also trigger our regional filtration system to swell up.

Which brings us to our fourth and final clinical puzzle,

lymphadenopathy.

Yes, let's define the terminology first.

Lymphadenopathy is a broad clinical term used to designate any abnormality of the lymph nodes, though it almost always refers to enlargement.

And lymphadenitis.

Lymphadenitis, noting the atasis suffix, specifically indicates that active inflammation is the direct cause of the lymph node enlargement.

Okay.

We classify this enlargement by location and distribution.

Regional lymphadenopathy means the swollen nodes are proximal, or close to, a specific localized site of infection.

Like a swollen neck node for a throat infection.

Exactly.

Systemic lymphadenopathy means you are palpating in large nodes in three or more sites dispersed systematically across the extranquinal lymphatic chains of the body.

You also must assess for tenderness, which is a major diagnostic differentiator.

Pain is good, right?

Counter -intuitively, yes.

If a lymph node is enlarged due to an acute, active infection, it is usually tender to the touch.

But chronically enlarged nodes, like those you see in advanced HIV infection or metastatic cancer, are typically non -tender.

Let's use age and history to build a differential diagnosis.

Imagine two patients who both present with a slow -growing neck mass, a classic presentation of cervical lymphadenopathy.

Patient one is a young adult with absolutely no history of tobacco or ethanol use.

In that specific patient, the likelihood of a neoplasm or cancer is minimal.

It is much more likely to be an infectious or inflammatory process.

Does the exact location in the neck help?

It does help narrow it down further.

Enlarged anterior neck nodes are strongly associated with streptococcal pharyngitis, while enlarged posterior neck nodes point more toward viral pharyngitis.

Okay, now consider patient two.

They are over 70 years old with a remote history of heavy tobacco use, presenting with that exact same slow -growing neck mass.

The clinical suspicion shifts completely.

Because of their advanced age and tobacco history, that slow -growing neck mass is highly likely to be lymphoma.

Age and lifestyle factors dramatically alter your baseline differential.

If that slow -growth enlargement persists, what is the next step in management?

Persistent, slow -growing lymph node enlargement, especially when your differential leans toward malignancy, warrants immediate consideration for lymph node aspiration and cytological evaluation.

To actually look at the cells.

You need to analyze the actual tissue to make a definitive diagnosis.

I wanna slow down and focus on how HIV complicates this differential diagnosis, because it presents in wildly different ways, depending on the stage of the disease.

HIV complicates lymphadenopathy significantly.

The average HIV -infected patient is younger than 50, and they frequently have a concurrent history of alcohol, tobacco, or other sexually transmitted infections.

Which can all cause swelling on their own.

Exactly, all of which can independently cause nodal abnormalities.

Furthermore, the nodes aren't just localized to the neck.

With HIV, lymphadenopathy can manifest systemically in the neck, the axillae, the inguinal region, the breasts, and the thorax.

Why do the nodes swell early in the disease versus late in the disease?

I feel like that distinction is really important for exams.

That is the key to understanding HIV -related lymphadenopathy.

In the early and middle stages of HIV, the lymphadenopathy is typically reactive.

Meaning the body is still fighting back.

Yes, the immune system is still functioning, and the nodes are physically enlarging as they react to the presence of the HIV virus itself.

However, in the late or advanced stages of HIV, the immune system has collapsed.

So it's not reacting to the virus anymore?

No, the nodes are no longer reacting to the virus.

Instead, they're being taken over by opportunistic infections or malignancies that the body can no longer fight off.

Like what?

In these late stages, the lymphadenopathy is usually caused by lymphoma, human papillomavirus -associated cancers, or concurrent severe infections with cytomegalovirus,

toxoplasmosis, or mycobacterium avium complex, also known as MEC.

Okay, we just covered a massive amount of clinical ground.

Let's do a rapid recap to lock this in for you.

We tracked the cellular cleanup of bruises, noting how macrophages break down red blood cells into hemocytarin and hematordin, shifting the bruise from red to green to yellowish -brown.

We differentiated functional fatigue from medical fatigue using the clock worse in the morning points to mental health, worse in the evening points to somatic issues like anemia due to oxygen demand.

We calculated step -by -step warfarin dosing and explored why FUO criteria changes from one week in the hospital to three weeks in an outpatient clinic.

And finally, we used age and node tenderness to rule out lymphomas in lymphadenopathy and track the systemic spread of nodes in HIV.

You have the foundational logic now.

You aren't just memorizing criteria.

You are reasoning through the pathophysiology.

But before you close your book and prep for your exam, consider the interconnectedness of these four symptoms.

We studied them in separate silos today, but in the human body, they constantly overlap.

A single underlying hematological condition could theoretically present with all four complaints simultaneously.

Absolutely.

Think about a patient with undiagnosed leukemia.

They could walk into your clinic presenting with spontaneous bruising because the abnormal marrow production has caused severe thrombocytopenia.

They could complain of paralyzing, chronic cancer -related fatigue that isn't fixed by sleep.

They might be running a persistent, low -grade chronic fever as an advanced sign of the malignancy.

And when you palpate their neck and axillae, you might find slow -growing, non -tender systemic lymphadenopathy.

One disease presenting as four distinct, overlapping complaints.

That is exactly why a thorough, holistic assessment is vital.

You cannot just treat the symptom.

You have to trace the logic back to the source.

You are gonna do great on your exam and you are gonna be an incredible clinician.

A warm thank you from the Last Minute Lecture Team.